1,016.97 USD
↗ 1.22 (0.12%)PRE MARKET (AS OF 08:02 AM EDT)
Open?$1,014.00
High?$1,025.00
Low?$1,012.78
Prev. Close?$1,015.75
Volume?16.7K
Avg. Volume?3.3M
VWAP?$1,018.66
Rel. Volume?0.01x
Bid / Ask
Bid?$1,015.00 × 40
Ask?$1,018.41 × 40
Spread?$3.41
Midpoint?$1,016.70
Valuation & Ratios
Market Cap?905.8B
Shares Out?941.7M
Float?851.3M
Float %?90.1%
P/E Ratio?35.83
P/B Ratio?29.03
EPS?$28.35
Dividend?0.62%
Ex-Dividend?2026-05-15
News
Profile
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Themes
Employees
50.0K
Market Cap
882.7B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1970-07-09
Address
LILLY CORPORATE CTR
INDIANAPOLIS, IN 46285
Phone: (317) 276-2000
INDIANAPOLIS, IN 46285
Phone: (317) 276-2000
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.50Adequate
Quick Ratio?1.10Adequate
Cash Ratio?0.14Low
Debt/Equity?1.39Moderate
ValuationRICHLY VALUED
Score33/100
P/E?35.8PRICEY▾
P/B?29.03HIGH▾
P/S?12.54HIGH▾
P/FCF?76.6PRICEY▾
EV/EBITDA?26.1HIGH▾
EV/Sales?13.06HIGH▾
Returns & Efficiency
ROE?81.0%STRONG▾
ROA?21.7%STRONG▾
Cash Flow & Enterprise
FCF?$11.8B
Enterprise Value?$943.9B
Fundamentals ratios updated end of day